ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 152 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2015. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,330,000 | -16.9% | 32,089 | -3.8% | 0.02% | -10.7% |
Q4 2021 | $2,805,000 | -7.6% | 33,361 | -0.8% | 0.03% | -6.7% |
Q3 2021 | $3,035,000 | +1.6% | 33,646 | +7.5% | 0.03% | +3.4% |
Q2 2021 | $2,986,000 | -35.6% | 31,311 | -23.1% | 0.03% | -40.8% |
Q1 2021 | $4,639,000 | -22.1% | 40,743 | -5.2% | 0.05% | -27.9% |
Q4 2020 | $5,952,000 | +65.0% | 42,997 | -2.1% | 0.07% | +41.7% |
Q3 2020 | $3,608,000 | +40.3% | 43,904 | +33.6% | 0.05% | +33.3% |
Q2 2020 | $2,571,000 | +60.8% | 32,868 | -8.7% | 0.04% | +33.3% |
Q1 2020 | $1,599,000 | -0.2% | 35,988 | -4.1% | 0.03% | +35.0% |
Q4 2019 | $1,603,000 | -0.8% | 37,532 | -0.7% | 0.02% | -9.1% |
Q3 2019 | $1,616,000 | -33.0% | 37,784 | -0.5% | 0.02% | -35.3% |
Q2 2019 | $2,412,000 | -8.4% | 37,989 | +0.1% | 0.03% | -10.5% |
Q1 2019 | $2,633,000 | +62.4% | 37,964 | +1.8% | 0.04% | +40.7% |
Q4 2018 | $1,621,000 | -42.8% | 37,293 | +0.4% | 0.03% | -32.5% |
Q3 2018 | $2,835,000 | -2.1% | 37,143 | -1.4% | 0.04% | -7.0% |
Q2 2018 | $2,895,000 | +49.8% | 37,660 | -0.7% | 0.04% | +43.3% |
Q1 2018 | $1,933,000 | +11.5% | 37,910 | +1.5% | 0.03% | +15.4% |
Q4 2017 | $1,733,000 | -13.3% | 37,360 | -0.4% | 0.03% | -21.2% |
Q3 2017 | $1,998,000 | -14.2% | 37,507 | 0.0% | 0.03% | -17.5% |
Q2 2017 | $2,330,000 | -10.3% | 37,507 | -2.1% | 0.04% | -13.0% |
Q1 2017 | $2,597,000 | +10.3% | 38,320 | +14.4% | 0.05% | +4.5% |
Q4 2016 | $2,354,000 | -1.4% | 33,483 | -0.5% | 0.04% | -8.3% |
Q3 2016 | $2,387,000 | +45.0% | 33,647 | 0.0% | 0.05% | +37.1% |
Q2 2016 | $1,646,000 | -22.7% | 33,647 | 0.0% | 0.04% | -25.5% |
Q1 2016 | $2,130,000 | -43.3% | 33,647 | +0.4% | 0.05% | -44.0% |
Q4 2015 | $3,758,000 | +18.3% | 33,497 | +1.5% | 0.08% | +12.0% |
Q3 2015 | $3,178,000 | +210.4% | 33,000 | +230.0% | 0.08% | +240.9% |
Q2 2015 | $1,024,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |